Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001398022-10-000003
Filing Date
2010-07-07
Accepted
2010-07-07 16:22:17
Documents
1
Effectiveness Date
2010-07-07
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 16517
  Complete submission text file 0001398022-10-000003.txt   18023
Mailing Address BELLEVUE HOSPITAL CENTER 462 First Avenue, Bldg. A, Ste. 908 New York NY 10016
Business Address BELLEVUE HOSPITAL CENTER 462 First Avenue, Bldg. A, Ste. 908 New York NY 10016 646-381-6680
Vivaldi Biosciences Inc (Filer) CIK: 0001398022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-144553 | Film No.: 10942168